Compare PHAR & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHAR | MNTK |
|---|---|---|
| Founded | 1988 | 1980 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 885.7M | 202.0M |
| IPO Year | 2020 | 2020 |
| Metric | PHAR | MNTK |
|---|---|---|
| Price | $13.98 | $1.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $38.33 | $1.80 |
| AVG Volume (30 Days) | 4.4K | ★ 194.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $176,382,000.00 |
| Revenue This Year | $10.04 | $18.55 |
| Revenue Next Year | $2.51 | $12.68 |
| P/E Ratio | $3,041.22 | ★ $146.00 |
| Revenue Growth | N/A | ★ 0.37 |
| 52 Week Low | $9.54 | $1.07 |
| 52 Week High | $21.34 | $2.57 |
| Indicator | PHAR | MNTK |
|---|---|---|
| Relative Strength Index (RSI) | 63.84 | 55.75 |
| Support Level | $12.98 | $1.59 |
| Resistance Level | $14.81 | $1.72 |
| Average True Range (ATR) | 0.40 | 0.09 |
| MACD | 0.22 | 0.01 |
| Stochastic Oscillator | 93.23 | 79.25 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.